These data indicate that anti-PD-1 antibodies are still functional at the time of resistance and maintain the ability to prevent inhibitory signals through PD-1 in the tumour microenvironment and suggest that mechanisms other than PD-1:PD-L1 interaction are likely important in adaptive resistance. This evidence concerns the gene CD274 and neoplasm.